Research on the lungs and respiratory health. Covers asthma prevention, immune cell activity, age-related decline, and pulmonary care.
The American College of Chest Physicians has launched CHEST Pulmonary, a new online publication dedicated to pulmonary and sleep medicine. The journal features original research, case series, and reviews on various topics, including implementation science and artificial intelligence applications.
Researchers are studying ways to update pulse oximeter technology to address limitations including overestimation in patients with darker skin tones and motion artifact. The goal is to improve the accuracy of oxygen saturation readings, particularly for diverse groups and in multiple settings.
Researchers found that a triple combination therapy of elexacaftor, tezacaftor, and ivacaftor improves lung function and reduces inflammation in patients with cystic fibrosis. The treatment's positive effects last over 12 months, offering hope for better management of the disease.
Researchers at CU Anschutz Medical Campus have found that vaping nicotine during pregnancy can be detrimental to the baby, disrupting bone and lung development. The study suggests that nicotine in e-cigarettes is just as harmful as that in traditional cigarettes.
Researchers at KIT have developed nanoparticles that can carry antibiotics directly to the lungs, increasing drug concentration and reducing resistance. The nanocarriers, containing Bedaquilin or BTZ-043, overcome biological barriers and show effectiveness in treating multidrug-resistant tuberculosis.
A study published in Radiology found that AI algorithms with high diagnostic accuracy improved radiologists' detection of lung cancers on chest X-rays. High-accuracy AI led to more frequent changes in reader determinations, suggesting increased human trust in AI.
Researchers found that when a patient's congestive heart failure is mentioned during the initial check-in process, emergency room physicians are less likely to test for pulmonary embolism, potentially leading to delays in diagnosis. This anchoring bias can delay crucial testing and diagnosis of deadly medical conditions.
A study published in Annals of the American Thoracic Society found that race-neutral lung function interpretation could lead to more equitable access to lung transplants for Black patients. The researchers analyzed data from over 8,900 patients and discovered that a race-specific approach resulted in lower Lung Allocation Scores (LAS) ...
COPD patients treated with dupilumab experienced rapid and sustained improvements in disease, as measured by reduced acute exacerbations, better lung function, and improved quality of life. This is the first biologic to show clinical outcomes improvement in COPD.
A recent study unveiled the doorway that SARS-CoV2 uses to slip inside cells undetected. Cholesterol clusters make up this door, allowing the virus to infect human cells. Regular exercise and mechanical force can disrupt these cholesterol aggregates, reducing the risk of infection.
The study analyzed historical data on coal miners in China, revealing a strong correlation between raw coal production, mining technology, and CWP incidence. The researchers identified key turning points in disease incidence, linked to changes in diagnostic criteria and labor management, as well as coal industry policy reforms.
Researchers found female babies with CDH have a 32% higher risk of dying within 30 to 60 days of birth compared to males. The study, using medical records from an international registry, suggests that lower birth weights for females may be linked to the disparity in survival rates.
Researchers found that 'concerning' CT imaging results were associated with lower clinical outcomes and shorter hospital stays in low-risk patients with acute pulmonary embolism. This suggests that emergency physicians may be managing these patients differently, leading to unnecessary hospitalizations.
Researchers at the University of Cincinnati have discovered two existing drugs that show signs of being effective in treating lymphangioleiomyomatosis (LAM), a rare and devastating lung disease. The study found that these drugs target a novel pathway dysregulated in LAM, which could lead to the development of a cure.
Researchers found a link between short telomeres in ATII cells and lung fibrosis in post-COVID-19 patients. The study revealed loss of ATII cellularity and shorter telomeres concomitant with increased fibrotic lung parenchyma remodeling.
The June issue of CHEST features 49 articles on clinically relevant topics, including asthma, COPD, and critical care. The journal offers web and multimedia resources to expand the reach of its research.
A University of Pittsburgh study found that TV medical dramas prompted middle schoolers to engage in discussion about vaping dangers after viewing clips featuring fictional adolescents with vaping-associated lung disease. The study suggests using entertainment television as a tool for dialogue about the health effects of e-cigarette use.
Researchers created a detailed snapshot of the structure of human cilia using advanced microscopy and artificial intelligence techniques. The study found that key elements of the axoneme structure are missing in people with primary ciliary dyskinesia, leading to defective cilia and breathing difficulties.
Lung mesenchymal cells have been identified in a new experimental model, enabling the study of pulmonary diseases such as fibrosis and interstitial lung disease. The researchers used an iPSC line carrying a lung mesenchyme-specific fluorescent reporter to test growth factors and small molecules, finding that stimulating retinoic acid a...
Researchers used infected stem cells to study COVID-19's impact on organs, identifying effective anti-viral drugs for treatment. The study found distinct antiviral profiles in heart and lungs, paving the way for new therapeutic options.
Researchers found a peptide from venomous fish Thalassophryne nattereri that controls lung inflammation and airway hyperreactivity. The molecule, TnP, inhibited cytokine production and prevented mucus-producing cell hyperplasia, making it a potential candidate for treating asthma.
Research by West Virginia University professor Sean Tu found that orphan drugs earn pharmaceutical companies almost as much as those marketed to the general public. The Orphan Drug Act incentivizes companies with tax credits, longer patent exclusivity, and easier FDA review for treating rare diseases.
Researchers at Texas Biomedical Research Institute have developed a new cell culture model to generate human alveolar macrophages, the most critical immune cells in the lungs. This model allows for easier and inexpensive investigation of lung inflammatory diseases and testing of new therapies.
The Human Lung Cell Atlas provides insights into lung biology by combining data from nearly 40 studies, revealing rare cell types and cellular differences between healthy people. The study found common cell states between lung fibrosis, cancer, and COVID-19, offering new ways of understanding lung disease.
A retrospective study found a 24% response rate to Docetaxel among patients with stage IV non-small cell lung cancer who experienced progression on immunotherapy. The median progression-free survival was 3 months, suggesting chemotherapy may still play an important role in treatment after immunotherapy failure.
SMART researchers have discovered a novel combination therapy using rifaximin and clarithromycin to treat antibiotic-resistant Mycobacterium abscessus infections. The study found that rifaximin potentiates clarithromycin against M. abscessus, increasing its sensitivity and effectiveness in killing the bacteria.
Researchers have developed a therapy using nanocarriers engineered from adult skin cells that curb inflammation and tissue injury in damaged mouse lungs. The treatment has shown promise for treating acute respiratory distress syndrome (ARDS), a condition that leads to respiratory failure and puts patients on ventilators.
UofL researchers, led by Jun Yan, will investigate the causes of immune system overresponse in COVID-19 patients, leading to severe lung disease and death. They aim to develop methods to predict, prevent or control this response with potential treatments for other conditions.
A new study found that obstructive sleep apnea causes widespread changes in gene activity in mice, affecting up to 16% of genes, particularly in lung tissue. The findings may lead to diagnostic and therapeutic approaches, including blood tests tracking dysregulated gene products.
Researchers found genetic similarities among strains of Mycobacterium abscessus that cannot be explained by direct person-to-person transmission. Instead, they suggest the pathogen is acquired from environmental exposures, with implications for hospital precautions and public health.
Scientists at La Jolla Institute for Immunology found that MAIT cells can be tuned to fight different pathogens via their metabolism, with two distinct subtypes responding to sugar and fat. This discovery may inspire new vaccines and cell therapies to boost the immune response against specific pathogens.
A study by University of Technology Sydney found that plants can remove 97% of toxic compounds, including cancer-causing pollutants, from indoor air in just eight hours. This breakthrough discovery highlights the critical role played by indoor plants and green walls in improving air quality.
Researchers from Mount Sinai Health System will present studies on pediatric pulmonary vascular disease, asthma, and sleep disorders. The findings focus on prevalence of pulmonary hypertension in children with severe obstructive sleep apnea and associations between diet and lung function decline.
A retrospective analysis of patient data suggests that targeting mucus plugs in the lungs may help prevent deaths from COPD. The study found that patients with mucus plugs had a higher mortality rate compared to those without, with significant associations across different disease phases.
Researchers found variant cells in lungs of IPF patients that can drive fibrosis and inflammation. These cells may be targeted for future therapy, offering new hope for treatment.
Researchers discovered that air pollution particles trigger autophagy, a cellular defense process, which has an upper threshold and may reduce its effectiveness against other threats. This finding provides new insights into the link between air pollution and lung disease.
Researchers from China explore the mechanisms of action and clinical data of bispecific antibodies, which have shown promise in increasing cytotoxicity against cancerous cells and enhancing immune response towards tumor clearance. Several bsAbs are being evaluated in phase I-III clinical trials for lung cancer treatment.
The May issue of the CHEST journal features cutting-edge research on pulmonary, critical care, and sleep medicine. The journal also highlights awareness for cystic fibrosis, a once-fatal childhood condition now affecting adults.
Researchers discovered a link between MCEMP1 protein on mast cells and severe asthma. Inhibiting this protein could provide relief for patients with severe asthma by reducing inflammation in the airway and lungs. The study provides critical information for developing new therapies for long-term lung conditions.
Joseph P. Mizgerd receives ATS Recognition Award for his work on lung immunology and respiratory infection, focusing on mechanisms of immune resistance and tissue resilience. He is also a dedicated mentor to lung scientists through the NHLBI-funded T32 training program.
Researchers at McMaster University have found that solriamfetol is the most effective treatment for excessive daytime sleepiness (EDS) in individuals with obstructive sleep apnea (OSA). A systematic review of 14 clinical trials and analysis of data from various databases revealed solriamfetol to be the best option.
A new study found that quitting smoking before a lung cancer diagnosis is associated with higher survival rates. Former smokers who stopped smoking years before their diagnosis had significantly longer survival than current and former smokers diagnosed with non-small cell lung cancer.
Researchers discovered crystalline silica in lungs of coal miners with non-targeted job duties, increasing the risk of severe black lung disease. The study highlights the importance of monitoring silica exposure in all coal miners, regardless of job duties.
Nearly half of COVID-19 patients develop secondary bacterial pneumonia, which can lead to death. Machine learning analysis found that this complication offsets the mortality rate from the viral infection itself.
Researchers investigated the cardiovascular effects of glucocorticoids on chicken embryos, finding that Betamethasone (Beta) caused more severe growth restriction, cellular stress, and cardiac dysfunction compared to Dexamethasone (Dex). Dex triggered oxidative stress, while Beta sustained glucocorticoid receptor activation
Researchers successfully delivered stabilized divalent siRNA molecules to animal models that blocked SARS-CoV-2 and prevented infection. The technology is adaptable for other pulmonary diseases such as pulmonary fibrosis and respiratory viruses.
The National Institutes of Health recognizes World Asthma Day and highlights innovative research on asthma, its causes and treatments. Several NIH institutes conduct and support asthma-related research, including NIEHS, NHLBI, and NIAID.
Researchers at the University of Missouri identified occludin protein as a mediator for cell-to-cell transmission of coronavirus. The study found that damaged occludin protein enables virus replication and spread to neighboring cells, worsening symptoms.
Researchers have developed advanced human lung models in the lab, allowing for accelerated discovery of new drugs and reduced reliance on animal testing. The mini lungs can be personalized to individual patients and tested for a range of reactions, including toxicity from pollutants.
A study by University of Alabama at Birmingham researchers reveals that cadmium-induced inflammation increases the severity and mortality of lung infections. The findings suggest that targeting the regulation of PPAR-gamma in macrophages may protect against severe pneumonia.
A new study reveals that young children diagnosed with pulmonary tuberculosis are at an increased risk of subsequent wheezing, poor lung function, and reduced height and weight. The study found that children who developed PTB before six months old had more than double the risk of wheezing after 6 months.
The American Roentgen Ray Society presents its 2023 Honorary Lecture on Advanced High-Resolution CT, dedicated to the late Dr. W. Richard Webb, who transformed thoracic imaging with his foundational work in HRCT. The lecture explores multiple conditions diagnosed via HRCT and the radiologist's role on multidisciplinary teams.
A study by University of Rochester Medical Center researchers reveals how a biological clock molecule contributes to lung scarring. Low levels of REV-ERBα have been linked to increased collagen production and worse lung damage in patients with pulmonary fibrosis.
Researchers found that p21 knockout mice experienced reduced senescent cell presence, alleviated chronic lung inflammation, and improved fitness. Resident epithelial and endothelial cells played a significant role in mediating the p21-dependent inflammatory response.
A novel treatment approach called balloon pulmonary angioplasty has been shown to be effective in treating chronic blood clots in lung arteries. The procedure improves exercise capacity and quality of life, with some patients able to stop medications altogether. Refinements in technique have improved the procedure's safety and efficacy.
The CHEST journal April issue features cutting-edge research on asthma, chronic obstructive pulmonary disease (COPD), and sarcoidosis. Key findings include the potential of efzofitimod as a treatment for managing sarcoidosis. The journal also showcases innovative approaches to clinical practice and education in chest medicine.
Researchers developed a biologically inspired 'vaping robot' to mimic human breathing patterns and tested commercially available e-liquids containing menthol. The study found that menthol vapers took shallower breaths and had poorer lung function compared to non-menthol smokers, regardless of age or smoking history.
A study published in Annals of the American Thoracic Society has identified disparities in patients receiving extracorporeal membrane oxygenation (ECMO) treatment for severe respiratory illness. Men and those with private health insurance are more likely to receive ECMO, while women and Medicaid recipients are less likely.
Researchers found decreased lung injury, coughing up blood, and mortality rates after balloon pulmonary angioplasty between 2013 and 2022. The minimally invasive procedure is now considered a safer option for inoperable CTEPH patients.
The study found that antibiotics slow down biofilm growth and QS molecule production across both strains, with surface type having a significant effect on the non-mucoid strain. The patterned structure was associated with longer latencies before expression of QS molecules were at their peak.